The
Wednesday, 13th October 1999 |
Biotech Seeds Can Be Good For The WorldBiotechnology is surely the most powerful tool ever put in the hands of agricultural
research, or medical research, for that matter. Using advanced knowledge of plant
genes, it is the same tool that has provided more than 100 medical products including
insulin, hepatitis vaccine and products for cardio-vascular disease. But where
scientists and development organizations see better health and nutrition for hundreds
of millions, others see danger. There are some genuine concerns about corporate
ethics and potential impacts on health and the environment. But many of the fears
are imaginary or misplaced.
The announcement last week by Monsanto, the giant American chemical company,
that it will disavow use of the "terminator" seed sterility technology is a
welcome step toward assuaging some of these concerns,particularly in developing
countries. Terminator technology prevents plants from producing fertile seeds,
forcing farmers to buy more seed from a multinational corporation rather than
using seed from the previous year's crop. Storing harvested seed for sowing
lay behind the success of the Green Revolution, which increased crop output
throughout the Third World. Terminator technology would have threatened our
attempts to feed the world in the next century.
But there remains a real danger that these controversies, if they continue,
may so polarize consumers, producers, industry and government in both the developed
and developing countries that it will become impossible for developing countries
to realize substantive benefits from plant biotechnology.
Other concessions must be made by the biotechnology companies. Most
important, they need to share their technologies and genetic information
with public plant breeders working for poor farmers. They should also agree
to conform to the plant variety protection system, rather than resort to
restrictive patents. This would permit public plant breeders to use seed to
produce further improvements in a plant variety.
It is also important that those who enjoy the comforts of living in industrialized
societies do not act to limit human initiative in an area of research that is
so vital to so many people.
Even so, we should proceed with biotechnology at a pace moderate enough to
anticipate harmful effects. Vitamin A and iron deficiencies, maladies practically
unknown in the United States and other industrialized countries, could potentially
be banished among people in the developing countries whose staple diet is rice,
thanks to a new variety of genetically modified rice that dramatically improves
the dietary supply of vitamin A and iron. At least 400 million women of child-bearing
age suffer from anemia as a result of iron deficiency. This can lead to physical
and mental retardation, premature births and natal mortality. And more than
100 million children do not get enough vitamin A, the lack of which worsens
the course of many infections and is the leading cause of blindness in developing
countries. Some 2 million children die each year indirectly as a result of vitamin
A deficiency. Following comprehensive tests, the new genetically modified golden
rice will be made freely available for use by poor farmers in rice-eating regions
within several years.
Funded by the Rockefeller Foundation and the European Union, this advance
in biotechnology could noticeably reduce childhood and maternal morbidity and
mortality rates through much of the developing world. Yet an even larger challenge
looms. In the next two decades, there will be an additional 1.5 billion people
to feed. But crop yields have ceased to grow as fast as they did during the
Green Revolution, and the availability of arable land in Africa, Asia and Latin
America is dwindling.
If nothing is done, by the year 2020 the number of undernourished could
exceed a billion people.
The tools of biotechnology are going to be essential if crop-yield ceilings
are to be raised, the environment preserved through reduction of pesticide use,
the nutrient value of basic foods increased and farmers on less-favored lands
provided with varieties better able to tolerate drought, salinity and lack of
soil nutrients. Let's hope that biotechnology's harvest will be less hunger
and greater health for humanity.
|
|
Monsanto in the UK | Biotech Primer | Knowledge Centre | Discussion Copyright Monsanto Company |
||